Oncothyreon (ONTY)

Add to Watchlists
Create an Alert
2.89 +0.01  +0.35% NASDAQ Apr 24, 8:00PM BATS Real time Currency in USD
View Full Chart
ONTY Price Chart
View All Events

ONTY Events

Date Type Description
Mar 13 Misc Q4 2013 Oncothyreon Inc. Earnings Conference Call
Mar 13 Earnings Q4 2013 Oncothyreon Inc. Earnings Results. Estimate: -0.10.
Nov 12 Misc Oncothyreon Announces Third Quarter 2013 Financial Results Conference Call
Nov 12 Earnings Oncothyreon Announces Third Quarter 2013 Financial Results. Estimate: -0.11.
Aug 06 Misc Oncothyreon Second Quarter 2013 Financial Results Conference Call
Aug 06 Earnings Second Quarter 2013 Financial Results. Estimate: -0.14.
Jun 13 Misc AGM Event for Oncothyreon Inc
May 09 Earnings Oncothyreon Announces First Quarter 2013 Financial Results Conference Call. Estimate: -0.11.
May 09 Misc Oncothyreon First Quarter 2013 Financial Results Conference Call
View All Performance Charts

ONTY Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Oncothyreon is up 12.84% over the last year vs S&P 500 Total Return up 21.54%, Actelion up 67.22%, and Array BioPharma down 34.14%.

Get Quote for
Advertisement

Portfolio Strategies Featuring ONTY

Did Oncothyreon make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ONTY Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Washington
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Oncothyreon Inc., is a clinical-stage biopharmaceutical company. It develops and markets synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ONTY 2.89 +0.01 +0.35% 204.95M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.